[Which treatment should children with recurrent urinary infections, without anatomical anomalies, receive?]

Area of Science:

• Pediatric Nephrology
• Infectious Diseases
• Pharmacology

Background:

• Recurrent urinary tract infections (UTIs) pose a significant health challenge in children.
• Identifying optimal treatment strategies for pediatric UTIs without anatomical abnormalities is crucial for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of different treatment regimens for recurrent lower urinary tract infections in children lacking anatomical abnormalities.
• To compare prophylactic antibiotic therapy, oxybutinin, and combination therapy.

Main Methods:

• A clinical study involving 150 children (aged 4-36 months) with recurrent UTIs and no anatomical abnormalities.
• Children were randomized into three groups: antibiotic prophylaxis, oxybutinin, or a combination of both.
• Treatment efficacy was assessed by UTI recurrence, hospitalization rates, nutritional status, and treatment duration.

Main Results:

• The combination therapy group (antibiotic + oxybutinin) showed the lowest UTI recurrence rate (3/50) and shortest treatment duration.
• Oxybutinin monotherapy resulted in fewer UTIs (14/50) and improved nutritional status compared to antibiotic prophylaxis alone (44/50).
• Antibiotic prophylaxis alone was associated with more frequent UTIs, hospitalizations, and malnutrition.

Conclusions:

• Combination therapy with prophylactic antibiotics and oxybutinin is the most effective treatment for children with recurrent UTIs and no anatomical abnormalities.
• Oxybutinin monotherapy offers an alternative treatment option, improving outcomes compared to antibiotic prophylaxis alone.
• Prophylactic antibiotic therapy alone requires longer treatment periods and is less effective in preventing recurrent UTIs in this population.